Tag: Generic Pharmaceuticals

Pay for Delay Nexium Lawsuit

Pay-for-Delay Lawsuit Involving Nexium Reopened by Federal Court

In the Nexium pay-for-delay multidistrict litigation accusing drug companies of violating antitrust laws by agreeing to delay entry of a generic version of AstraZenca’s heartburn drug Nexium, federal Judge William Young may be reconsidering some of[...]

Pay for Delay Drug Costs

Pay-for-Delay Tactics of Drug Manufacturers Considered by Supreme Court

The debate over "reverse payment" patent litigation settlements continues following the Supreme Court's decision in FTC v. Actavis that such agreements should be individually evaluated to determine whether they violate the anti-trust laws. Reverse payment settlements[...]